why choose us

First received: February 14, 2023

Clinical Trial: Nanodropper Use in Primary Open-Angle Glaucoma Patients: A Non-Inferiority Trial

Study Status: Completed

Recruit Status: RECRUITING

Condition: Ocular Hypertension

Study Type: INTERVENTIONAL


Official Title: Nanodropper Use in Primary Open-Angle Glaucoma Patients: A Non-Inferiority Trial

Brief Summary: This randomized, single-masked, crossover, non-inferiority trial aims to evaluate the safety and efficacy of Nanodropper-mediated microdrops of ocular hypotensive topical treatments (experimental intervention) compared to standard drops of the same medication(s) (active comparator) in Wilford Hall Ambulatory Surgical Center (WHASC) primary open-angle glaucoma (POAG) and ocular hypertension (OHTN) patients.

Read more